Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer.
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 03; 14(3):547-552.
View in:
PubMed
subject areas
Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological
B7-H1 Antigen
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Female
Follow-Up Studies
Humans
Immunotherapy
Lung Neoplasms
Male
Middle Aged
Prognosis
Programmed Cell Death 1 Receptor
Retrospective Studies
Survival Rate
authors with profiles
Ryan D Nipp